SAILIFE — SAI Life Sciences Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for SAI Life Sciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,696	12,171	14,652	16,946	21,925
Cost of Revenue
Gross Profit	5,445	7,119	9,259	11,357	16,216
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	8,385	11,511	12,991	14,257	17,362
Operating Profit	311	661	1,661	2,689	4,563
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	97	164	1,092	2,277	4,662
Provision for Income Taxes
Net Income After Taxes	62.3	99.9	828	1,701	3,489
Net Income Before Extraordinary Items
Net Income	62.3	99.9	828	1,701	3,489
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	62.3	99.9	828	1,701	3,489
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.054	0.497	3.98	8.74	16.7